Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  HIV Infection

  Free Subscription


1 AIDS Res Hum Retroviruses
1 Am J Epidemiol
1 Am J Med
5 Clin Infect Dis
7 HIV Med
10 J Acquir Immune Defic Syndr
1 J Immunol
3 J Infect Dis
2 J Med Virol
3 J Virol
1 Lancet
1 MMWR Morb Mortal Wkly Rep
5 N Engl J Med
1 Nat Med
2 Nature
1 Pediatr Infect Dis J
1 PLoS Med
6 PLoS One
1 Proc Natl Acad Sci U S A
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. GREGSON CL, Rehman AM, Rukuni R, Mukwasi-Kahari C, et al
    Perinatal HIV infection is associated with deficits in muscle function in children and adolescents: a cross-sectional study in Zimbabwe.
    AIDS. 2023 Nov 22. doi: 10.1097/QAD.0000000000003795.
    PubMed         Abstract available

  2. WILLIAMS PL, Karalius B, Patel K, Aschengrau A, et al
    Fetal growth assessed via ultrasound in relation to maternal HIV infection status and antiretroviral regimens.
    AIDS. 2023 Nov 22. doi: 10.1097/QAD.0000000000003796.
    PubMed         Abstract available

  3. VAN GEUNS D, Arts RJ, de Vries G, Wit FW, et al
    Screening for tuberculosis infection and effectiveness of preventive treatment among people living with HIV in low-incidence settings: a systematic review and meta-analysis.
    AIDS. 2023 Oct 12. doi: 10.1097/QAD.0000000000003747.
    PubMed         Abstract available

  4. CHAWKI S, Goldwirt L, Mouhebb ME, Gabassi A, et al
    Ex vivo rectal tissue infection with HIV-1 to assess time to protection following oral PrEP with TDF/FTC (a sub-study of the ANRS PREVENIR study).
    AIDS. 2023 Nov 16. doi: 10.1097/QAD.0000000000003789.
    PubMed         Abstract available

  5. HAIDAR L, Crane HM, Nance RM, Webel A, et al
    Weight loss associated with semaglutide treatment among people with HIV.
    AIDS. 2023 Nov 17. doi: 10.1097/QAD.0000000000003791.
    PubMed         Abstract available

  6. DAWIT R, Goedel WC, Reid SC, Doshi JA, et al
    Geographic variations of PrEP reversal and abandonment among US counties.
    AIDS. 2023 Nov 16. doi: 10.1097/QAD.0000000000003790.
    PubMed         Abstract available

  7. KNUDSEN AD, Eskelund CW, Benfield T, Zhao Y, et al
    Clonal hematopoiesis of indeterminate potential in Persons living with HIV.
    AIDS. 2023 Nov 16. doi: 10.1097/QAD.0000000000003788.
    PubMed         Abstract available

    AIDS Res Hum Retroviruses

  8. DONG S, Lu X, Wang Y, An N, et al
    Near-full-length genome analysis of a HIV-1 CRF01_AE/B recombinant strain among men who have sex with men in Chengde City, China.
    AIDS Res Hum Retroviruses. 2023 Nov 19. doi: 10.1089/AID.2023.0110.
    PubMed         Abstract available

    Am J Epidemiol

  9. WESSON P, Das M, Chen M, Hsu L, et al
    Evaluating a Targeted Minimum Loss-based Estimator for Capture-Recapture Analysis: An Application to HIV Surveillance in San Francisco, CA.
    Am J Epidemiol. 2023 Nov 17:kwad231. doi: 10.1093.
    PubMed         Abstract available

    Am J Med

  10. BINDAKHIL M, AlHassan G, Kilgore-Rodriguez R, Abdelsayed R, et al
    Multifocal Oral Mucosal Nodules in a Patient Living With HIV.
    Am J Med. 2023 Nov 16:S0002-9343(23)00711-8. doi: 10.1016/j.amjmed.2023.

    Clin Infect Dis

  11. VINIKOOR MJ, Hamusonde K, Muula G, Asombang M, et al
    Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia.
    Clin Infect Dis. 2023 Nov 24:ciad654. doi: 10.1093.
    PubMed         Abstract available

  12. GAUSI K, Mugerwa H, Siccardi M, Montanha MC, et al
    Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin.
    Clin Infect Dis. 2023 Nov 20:ciad700. doi: 10.1093.
    PubMed         Abstract available

  13. MISRA K, Huang JS, Udeagu CN, Forgione L, et al
    Pre-exposure prophylaxis (PrEP) use history in people with antiretroviral resistance at HIV diagnosis: Findings from New York City HIV surveillance and partner services, 2015-2022.
    Clin Infect Dis. 2023 Nov 17:ciad699. doi: 10.1093.
    PubMed         Abstract available

  14. ADACHI E, Owada R, Sato S, Kono M, et al
    Febrile gluteal inflammation evident on imaging findings after long-acting cabotegravir administration.
    Clin Infect Dis. 2023 Nov 16:ciad705. doi: 10.1093.

  15. MANHART LE, Leipertz G, Soge OO, Jordan SJ, et al
    Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions.
    Clin Infect Dis. 2023;77:1449-1459.
    PubMed         Abstract available

    HIV Med

  16. ALFORD K, Sidat S, Bristowe K, St Clair-Sullivan N, et al
    People with HIV and healthcare workers views on screening for cognitive impairment in people with HIV: A qualitative study.
    HIV Med. 2023 Nov 21. doi: 10.1111/hiv.13582.
    PubMed         Abstract available

  17. LU L, Ma Y, Cong Y, Zhou B, et al
    Comorbidity of Myasthenia gravis and Graves' disease as immune reconstitution-associated autoimmune disease in HIV infection: A case report and literature review.
    HIV Med. 2023 Nov 22. doi: 10.1111/hiv.13584.
    PubMed         Abstract available

  18. BOTTANELLI M, Galli L, Guffanti M, Castagna A, et al
    Are glucagon-like peptide 1 receptor agonists effective in decreasing body weight and body mass index in people living with diabetes and HIV?
    HIV Med. 2023 Nov 21. doi: 10.1111/hiv.13587.

  19. SHI J, Ying G, Zheng R, Zhang Z, et al
    Clinical significance and management of low-level HIV viremia in the era of integrase strand transfer inhibitors.
    HIV Med. 2023 Nov 22. doi: 10.1111/hiv.13585.
    PubMed         Abstract available

  20. DAWE J, Cassano D, Keane R, Ruth S, et al
    Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing.
    HIV Med. 2023 Nov 22. doi: 10.1111/hiv.13592.
    PubMed         Abstract available

  21. TREVILLYAN JM, Behrens G
    Ageing with HIV; a victory, a challenge and a call to action.
    HIV Med. 2023 Nov 22. doi: 10.1111/hiv.13591.

  22. HAN WM, Hiransuthikul A, Holroyd KB, Apornpong T, et al
    Impact of steatotic liver disease and non-alcoholic steatohepatitis on cognitive impairment in people living with HIV: A cross-sectional study.
    HIV Med. 2023 Nov 17. doi: 10.1111/hiv.13579.
    PubMed         Abstract available

    J Acquir Immune Defic Syndr

  23. VIGUERIE A, Song R, Bosh K, Lyles CM, et al
    Mortality among persons with HIV in the United States during the COVID-19 pandemic: a population-level analysis.
    J Acquir Immune Defic Syndr. 2023 Nov 20. doi: 10.1097/QAI.0000000000003347.
    PubMed         Abstract available

  24. TRUONG HM, Heylen E, Kadede K, Amboka S, et al
    HIV Pre-Exposure Prophylaxis (PrEP) Awareness and Use Among Adolescents in Kenya.
    J Acquir Immune Defic Syndr. 2023 Nov 21. doi: 10.1097/QAI.0000000000003338.

  25. RIEBENSAHM C, Berzigotti A, Surial B, Haerry D, et al
    Decreased physical activity and prolonged sitting time are associated with liver steatosis in people with HIV.
    J Acquir Immune Defic Syndr. 2023 Nov 21. doi: 10.1097/QAI.0000000000003328.
    PubMed         Abstract available

  26. CRANE HM, Nance RM, Ruderman SA, Haidar L, et al
    Venous thromboembolism among people with HIV: Design, implementation, and findings of a centralized adjudication system in clinical care sites across the United States.
    J Acquir Immune Defic Syndr. 2023 Nov 21. doi: 10.1097/QAI.0000000000003339.
    PubMed         Abstract available

  27. JIANG W, Ronen K, Osborn L, Drake AL, et al
    HIV viral load patterns and risk factors among women in prevention of mother-to-child transmission (PMTCT) programs to inform differentiated service delivery (DSD).
    J Acquir Immune Defic Syndr. 2023 Nov 15. doi: 10.1097/QAI.0000000000003352.
    PubMed         Abstract available

  28. DICKEY BL, Yanik EL, Thompson Z, Burkholder G, et al
    The association of HIV control and immunosuppression with risk of non-AIDS defining cancer risk among patients on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2023 Nov 16. doi: 10.1097/QAI.0000000000003350.
    PubMed         Abstract available

  29. MI T, Zhang J, Yang X, Chen S, et al
    Suicide ideation and attempt among people with HIV: A statewide population-level cohort analysis between 2005-2020.
    J Acquir Immune Defic Syndr. 2023 Nov 16. doi: 10.1097/QAI.0000000000003342.
    PubMed         Abstract available

  30. SHABA F, Balakasi K, Offorjebe OA, Nyirenda M, et al
    Facility HIV self-testing in outpatient departments: an assessment of characteristics and concerns of outpatients who opt-out of testing in Malawi.
    J Acquir Immune Defic Syndr. 2023 Nov 15. doi: 10.1097/QAI.0000000000003327.

  31. LIEGEON G, Brun A, Hamet G, Zeggagh J, et al
    Incidence and Management of Complex Kidney Situations Among On-demand and Daily HIV Pre-exposure Prophylaxis Users.
    J Acquir Immune Defic Syndr. 2023 Nov 16. doi: 10.1097/QAI.0000000000003346.

  32. ARNOLD EM, Kamal S, Rotheram-Borus MJ, Bridges SK, et al
    Factors Associated with Antiretroviral Adherence among Youth Living with HIV.
    J Acquir Immune Defic Syndr. 2023 Nov 17. doi: 10.1097/QAI.0000000000003345.
    PubMed         Abstract available

    J Immunol

    HIV Never Sleeps: Evidence to Support Early Antiretroviral Treatment.
    J Immunol. 2023;210:1181-1182.

    J Infect Dis

  34. COMBES JD, Didelot JM, Radenne S, Zaegel-Faucher O, et al
    Cumulative detection of anal high-grade squamous intraepithelial lesions over two-year follow-up in men who have sex with men living with HIV in France.
    J Infect Dis. 2023 Nov 16:jiad506. doi: 10.1093.
    PubMed         Abstract available

  35. HAIDAR G, Hodges JC, Bilderback A, Lukanski A, et al
    Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19 mRNA vaccine dose among immunocompromised individuals.
    J Infect Dis. 2023 Nov 16:jiad511. doi: 10.1093.
    PubMed         Abstract available

  36. KARAN A, Shah N, Garrigues JM, Alarcomicronn J, et al
    Surveillance of complicated mpox cases unresponsive to oral tecovirimat in Los Angeles County, 2022.
    J Infect Dis. 2023 Nov 23:jiad517. doi: 10.1093.
    PubMed         Abstract available

    J Med Virol

  37. AKBARI E, Milani A, Seyedinkhorasani M, Bolhassani A, et al
    HPV co-infections with other pathogens in cancer development: A comprehensive review.
    J Med Virol. 2023;95:e29236.
    PubMed         Abstract available

  38. BUCK AM, Deitchman AN, Takahashi S, Lu S, et al
    The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
    J Med Virol. 2023;95:e29216.
    PubMed         Abstract available

    J Virol

  39. CHANG J, Parent LJ
    HIV-1 Gag co-localizes with euchromatin histone marks at the nuclear periphery.
    J Virol. 2023 Nov 22:e0117923. doi: 10.1128/jvi.01179.
    PubMed         Abstract available

  40. YAPO V, Majumder K, Tedbury PR, Wen X, et al
    HIV-2 inhibits HIV-1 gene expression via two independent mechanisms during cellular co-infection.
    J Virol. 2023 Nov 22:e0187022. doi: 10.1128/jvi.01870.
    PubMed         Abstract available

  41. LIU Y, Binda CS, Berkhout B, Das AT, et al
    CRISPR-Cas attack of HIV-1 proviral DNA can cause unintended deletion of surrounding cellular DNA.
    J Virol. 2023 Nov 20:e0133423. doi: 10.1128/jvi.01334.
    PubMed         Abstract available


  42. CHEN TL, Chuang HK, Wu CY
    Violaceous Nodules on the Right Leg and Foot.
    JAMA. 2023 Nov 20. doi: 10.1001/jama.2023.20118.


    Preventing healers from becoming killers.
    Lancet. 2023;402:1805.

    MMWR Morb Mortal Wkly Rep

  44. NETTLETON WD, Kent JB, Lightheart K, Diesel JC, et al
    A Cluster of Ocular Syphilis Cases with a Common Sex Partner - Southwest Michigan, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1281-1287.
    PubMed         Abstract available

    N Engl J Med

  45. ALAM SR, Mureithi M, Ferrand R
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.

  46. BOETTIGER DC, Phillips AN, Newall AT
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.

  47. IOANNOU P, Filippatos TD, Kofteridis DP
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.

  48. OLALLA J, Pombo M
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.

  49. GRINSPOON SK, Ribaudo HJ, Douglas PS
    Pitavastatin and Cardiovascular Disease in HIV. Reply.
    N Engl J Med. 2023;389:e46.

    Nat Med

  50. Viral, cellular and immune aspects of non-suppressible HIV-1 viremia.
    Nat Med. 2023 Nov 23. doi: 10.1038/s41591-023-02688.


  51. DAM KA, Fan C, Yang Z, Bjorkman PJ, et al
    Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.
    Nature. 2023 Nov 22. doi: 10.1038/s41586-023-06639.
    PubMed         Abstract available

  52. LI W, Qin Z, Nand E, Grunst MW, et al
    HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes.
    Nature. 2023 Nov 22. doi: 10.1038/s41586-023-06762.
    PubMed         Abstract available

    Pediatr Infect Dis J

  53. MECHA J, Escudero JN, Richardson BA, Maleche-Obimbo E, et al
    Maternal HIV Status and Risk of Infant Mycobacterium Tuberculosis Infection as Measured by Tuberculin Skin Test.
    Pediatr Infect Dis J. 2023 Nov 22. doi: 10.1097/INF.0000000000004190.
    PubMed         Abstract available

    PLoS Med

  54. GALILEYA LT, Wasmann RE, Chabala C, Rabie H, et al
    Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
    PLoS Med. 2023;20:e1004303.
    PubMed         Abstract available

    PLoS One

  55. AYIEKO J, Charlebois ED, Maeri I, Owino L, et al
    Improving care engagement for mobile people living with HIV in rural western Kenya.
    PLoS One. 2023;18:e0288087.
    PubMed         Abstract available

  56. KAPETANAKIS A, Karakatsoulis G, Kyrou D, Ntourou I, et al
    The impact of frailty and illness perceptions on quality of life among people living with HIV in Greece: A network analysis.
    PLoS One. 2023;18:e0292787.
    PubMed         Abstract available

  57. GUURE C, Dery S, Afagbedzi S, Maya E, et al
    Correlates of prevalent HIV infection among adolescents, young adults, and older adult female sex workers in Ghana: Analysis of data from the Ghana biobehavioral survey.
    PLoS One. 2023;18:e0292686.
    PubMed         Abstract available

  58. GRAY AT, Macpherson L, Carlin F, Sossen B, et al
    Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293535.
    PubMed         Abstract available

  59. SANWO O, Iyamu I, Idemudia A, Badru T, et al
    Willingness to pay for antiretroviral therapy, viral load, and premium services; A contingent valuation survey of people living with HIV in southern Nigeria.
    PLoS One. 2023;18:e0289507.
    PubMed         Abstract available

  60. SU Y, Mukora R, Ndebele F, Pienaar J, et al
    Cost savings in male circumcision post-operative care using two-way text-based follow-up in rural and urban South Africa.
    PLoS One. 2023;18:e0294449.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  61. TWIZERIMANA AP, Becker D, Zhu S, Luedde T, et al
    The cyclophilin A-binding loop of the capsid regulates the human TRIM5alpha sensitivity of nonpandemic HIV-1.
    Proc Natl Acad Sci U S A. 2023;120:e2306374120.
    PubMed         Abstract available


  62. MAN-LIK CHOI E, Abu-Baker Mustapher G, Omosa-Manyonyi G, Foster J, et al
    Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in
    Vaccine. 2023 Nov 17:S0264-410X(23)01257-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.